Comment
. 2007 Sep 20;25(27):4318-20; author reply 4320.
doi: 10.1200/JCO.2007.12.2945.
Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications
- PMID: 17878487
- DOI: 10.1200/JCO.2007.12.2945
Item in Clipboard
Comment
Celecoxib induces MRP-4 in lung cancer cells: therapeutic implications
J Clin Oncol.
.
No abstract available
Comment on
-
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.J Clin Oncol. 2003 Jul 15;21(14):2645-50. doi: 10.1200/JCO.2003.07.127. J Clin Oncol. 2003. PMID: 12860939 Clinical Trial.
-
Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer.J Clin Oncol. 2006 Oct 20;24(30):4825-32. doi: 10.1200/JCO.2006.07.4773. J Clin Oncol. 2006. PMID: 17050867 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
